328 related articles for article (PubMed ID: 14300296)
1. INACTIVATED MEASLES VIRUS VACCINE SUBSEQUENTLY CHALLENGED WITH LIVE ATTENUATED MEASLES VIRUS VACCINE.
KIMURA M; ISHIGURO Y
Jpn J Med Sci Biol; 1965 Feb; 18():65-71. PubMed ID: 14300296
[No Abstract] [Full Text] [Related]
2. IMMUNIZATION WITH INACTIVATED MEASLES VIRUS VACCINE: EFFECT OF BOOSTER DOSE AND RESPONSE TO NATURAL CHALLENGE.
KARZON DT; RUSH D; WINKELSTEIN W
Pediatrics; 1965 Jul; 36():40-50. PubMed ID: 14313365
[No Abstract] [Full Text] [Related]
3. CLINICAL AND SEROLOGICAL OBSERVATIONS ON THE CHILDREN GIVEN ATTENUATED MEASLES VACCINE.
ARAI M; NAKAMURA M; AKAMATSU T; KIMURA M; KITAYAMA T; KOIDE G
Acta Paediatr Jpn; 1963 Dec; 14():9-16. PubMed ID: 14200614
[No Abstract] [Full Text] [Related]
4. FURTHER STUDY OF THE USE OF LIVE ATTENUATED MEASLES-VIRUS VACCINE.
CHU FT; CHANG IH; SUNG HY; LING CC
Paediatr Indones; 1964; 149():42-8. PubMed ID: 14279960
[No Abstract] [Full Text] [Related]
5. [FURTHER OBSERVATIONS ON THE PROTECTIVE EFFECTS AND SEROLOGICAL RESPONSE IN CHILDREN IMMUNIZED WITH KILLED MEASLES VIRUS VACCINE].
BRANCATO P; GULLO A; ALBANESE M
Riv Ist Sieroter Ital; 1964; 39():287-92. PubMed ID: 14177289
[No Abstract] [Full Text] [Related]
6. [EXPERIENCE IN VACCINATION WITH ATTENUATED MEASLES VIRUS. 3. IMMUNOLOGIC AND EPIDEMIOLOGIC STUDY AFTER A YEAR OF OBSERVATION].
HEVIA P; RODRIGUEZ M; UNDURRAGA O; ROSSELOT J; MENEGHELLO J
Pediatria (Santiago); 1963; 6():151-6. PubMed ID: 14080014
[No Abstract] [Full Text] [Related]
7. Inactivated measles virus vaccine. Subsequent challenge with attenuated live virus vaccine.
KARELITZ S; BERLINER BC; ORANGE M; PENBHARKKUL S; RAMOS A; MUENBOON P
JAMA; 1963 Jun; 184():673-9. PubMed ID: 13962482
[No Abstract] [Full Text] [Related]
8. Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus.
Norrby E; Enders-Ruckle G; Meulen V
J Infect Dis; 1975 Sep; 132(3):262-9. PubMed ID: 1159329
[TBL] [Abstract][Full Text] [Related]
9. MEASLES IMMUNIZATION WITH KILLED VIRUS VACCINE. SERUM ANTIBODY TITERS AND EXPERIENCE WITH EXPOSURE TO MEASLES EPIDEMIC.
RAUH LW; SCHMIDT R
Am J Dis Child; 1965 Mar; 109():232-7. PubMed ID: 14246070
[No Abstract] [Full Text] [Related]
10. COMBINED USE OF HUMAN GAMMA-GLOBULIN AND LIVE MEASLES-VIRUS VACCINE WITH REFERENCE TO SINGLE INOCULATION OF LIVE MEASLES-VIRUS VACCINE IN EARLY INFANCY.
FUJII R; MINAMITANI M; NAKAMURA K
Jpn J Med Sci Biol; 1965 Feb; 18():56-64. PubMed ID: 14300295
[No Abstract] [Full Text] [Related]
11. Clinical and immunological studies on a live attenuated measles virus vaccine in infants and children.
HALONEN P; FORSSELL P; HALONEN H; PETTAY O; STENSTROM R; OHMAN S; OKER-BLOM N
Acta Paediatr (Stockh); 1962 Jul; 51():401-8. PubMed ID: 13903975
[No Abstract] [Full Text] [Related]
12. [Measles vaccination. Israeli studies with live attenuated measles virus vaccine and gamma globulin].
LEVIN S; MOSES S; SHIMANSKY L; KRUGMAN S
Harefuah; 1962 Sep; 63():161-6. PubMed ID: 14464579
[No Abstract] [Full Text] [Related]
13. Studies of live attenuated measles virus vaccine in man. II. Appraisal of efficacy.
HILLEMAN MR; STOKES J; BUYNAK EB; WEIBEL R; HALENDA R; GOLDNER H
Am J Public Health Nations Health; 1962 Feb; 52(2)Suppl(Suppl 2):44-56. PubMed ID: 13907411
[No Abstract] [Full Text] [Related]
14. Studies of live attenuated measles virus vaccine in man. I. Clinical aspects.
STOKES J; WEIBEL R; HALENDA R; REILLY CM; HILLEMAN MR
Am J Public Health Nations Health; 1962 Feb; 52(2)Suppl(Suppl 2):29-43. PubMed ID: 13917383
[No Abstract] [Full Text] [Related]
15. MEASLES VACCINATION. II. ANTIBODY TITERS 8 TO 9 MONTHS AFTER VACCINATION WITH AN INACTIVATED VACCINE.
NORRBY E; CARLSTROEM G; LAGERCRANTZ R; GARD S
Acta Paediatr (Stockh); 1964 Nov; 53():533-40. PubMed ID: 14225879
[No Abstract] [Full Text] [Related]
16. MEASLES VACCINE FIELD TRIALS IN ALASKA. I. KILLED VACCINE FOLLOWED BY LIVE ATTENUATED VACCINE AND GAMMA-GLOBULIN WITH LIVE ATTENUATED VACCINE.
BRODY JA; MCALISTER R; EMANUEL I; ALEXANDER ER
JAMA; 1964 Aug; 189():339-42. PubMed ID: 14160504
[No Abstract] [Full Text] [Related]
17. VACCINATION OF INFANTS WITH LIVING ATTENUATED MEASLES VACCINE (EDMONSTON STRAIN) WITH AND WITHOUT GAMMA-GLOBULIN.
BENSON PF; BUTLER NR; GOFFE AP; KNIGHT GJ; LAURENCE GD; MILLER CL; POLLOCK TM
Br Med J; 1964 Oct; 2(5413):851-3. PubMed ID: 14185636
[No Abstract] [Full Text] [Related]
18. RESPONSE OF VOLTA CHILDREN TO LIVE ATTENUATED MEASLES VIRUS VACCINE.
MEYER HM; HOSTETLER DD; BERNHEIM BC; ROGERS NG; LAMBIN P; CHASSARY A; SMADEL JE
Bull World Health Organ; 1964; 30(6):769-81. PubMed ID: 14215184
[TBL] [Abstract][Full Text] [Related]
19. OBSERVATIONS ON THE FURTHER ATTENUATION OF MEASLES VIRUS AND ON LIVE VACCINES PREPARED FROM HIGHLY ATTENUATED LINES OF VIRUS.
CHU CM; KU YF; CHANG YH
Chin Med J; 1964 Aug; 83():483-96. PubMed ID: 14174535
[No Abstract] [Full Text] [Related]
20. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
Unalan H; Ustaçelebi S
Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
